<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Findings in computed tomography (CT) with or without contrast infusion were analyzed in 8 patients with <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>From the extent of calcification in the CT, <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber disease</z:e> can be classified into two types, localized and diffuse </plain></SENT>
<SENT sid="2" pm="."><plain>The extent of calcification or <z:hpo ids='HP_0002120'>cortical atrophy</z:hpo> is predictable, if it can be shown that enhanced areas in contrast infusion CT truly represent leptomeningeal <z:e sem="disease" ids="C0002992,C1411989" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">angiomatosis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, using enhanced CT, the capacity of prediciton as to whether the patient will have a localized or diffuse type of disease will be possible with further observations </plain></SENT>
</text></document>